You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

November 19, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Cirrhosis patients benefit from new hepatitis C drug

The new combination hepatitis C drug ledipasvir/sofosbuvir (Harvoni, Gilead Sciences) has been found to be highly effective in treating patients with cirrhosis who have not benefited from previous therapies. » Read about the controversy with ledipasvir/sofosbuvir

ADVERTISEMENT

Idiopathic Pulmonary Fibrosis (IPF)

IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen. While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Read More.

Patients who think they are allergic to penicillin probably are not

Many people who report an allergy to penicillin actually are not allergic to penicillin, according to a study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting, in Atlanta. » Find out the most accurate way to determine an allergy

Continuing Education

MTM essentials for weight management

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to educate pharmacists about the prevalence, health consequences, and nonpharmacologic and pharmacologic treatment options for obesity, with a focus on the recommendations made in the 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT12-FKX42.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs (ASPs) a priority

Combating antimicrobial resistance is a global concern that is most effectively addressed through antimicrobial stewardship programs. » Get started with your ASP

 

RELATED ARTICLES

FDA's new hep C approval: A step closer to a cure?

Penicillin 'allergy' label at hospital admission can lead to longer hospital stays

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group